Covid-19 Vaccine Equity Project – Kenya

As the COVID-19 pandemic continues to gain momentum globally, the need to vaccinate a majority of the population is becoming critical. Already, millions of doses of the COVID-19 vaccine have been administered across Kenya, yet many people remain hesitant to take the vaccine, slowing down the global vaccine rollout.

PATH's Living Labs, Amref, Dalberg, and JSI, are a group of designers, behavioural scientists, immunisation professionals, and health service providers/implementers. In partnership, we conducted research to understand the perceptions and motivations of Kenyans with regards to the COVID-19 vaccine to help boost its uptake amongst eligible populations through targeted campaigns.

Publication date: November 2021

Available materials

    1. Covid-19 Vaccine Equity Project – Kenya 507.6 KB PDF
    2. Addressing vaccine hesitancy in Kenya 6.1 MB PDF